Clinical Trial

Beta Glucan 500 and Biological Age and Immune Age

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-01; most recent amendment 2026-02-17.
Status change: Not Yet Recruiting → Completed 2026-02-17
Trial Details
NCT Number NCT07104929
Lead Sponsor OvationLab
Conditions Aging
Enrollment 60 participants
Start Date 2025-05-14
Primary Completion 2025-10-09 (estimated)
Study Completion 2025-10-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-19